NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$10.39 +0.56 (+5.70 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$10.39
Today's Range$10.04 - $10.47
52-Week Range$9.24 - $16.13
Volume4.34 million shs
Average Volume1.81 million shs
Market Capitalization$1.72 billion
P/E Ratio19.27
Dividend YieldN/A
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
Current SymbolNASDAQ:MDRX
Previous Symbol


Debt-to-Equity Ratio1.61
Current Ratio0.94
Quick Ratio0.94


Trailing P/E Ratio19.27
Forward P/E Ratio19.24
P/E Growth1.39

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.00
Cash Flow$1.7791 per share
Price / Cash Flow5.84
Book Value$6.42 per share
Price / Book1.62


EPS (Most Recent Fiscal Year)$0.47
Net Income$-152,600,000.00
Net Margins-0.25%
Return on Equity8.25%
Return on Assets2.14%


Outstanding Shares174,710,000
Market Cap$1.72 billion

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its Board of Directors has initiated a share buyback plan on Thursday, August 2nd 2018, which allows the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 11.3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, November, 1st. The software maker reported $0.13 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.14 by $0.01. The software maker had revenue of $536 million for the quarter, compared to analyst estimates of $546.09 million. Allscripts Healthcare Solutions had a positive return on equity of 8.25% and a negative net margin of 0.25%. Allscripts Healthcare Solutions's revenue was up 18.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.15 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, February 21st 2019. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY18 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.76. The company issued revenue guidance of $2.15-2.25, compared to the consensus revenue estimate of $2.17 billion.

What price target have analysts set for MDRX?

12 brokerages have issued 12-month price objectives for Allscripts Healthcare Solutions' stock. Their forecasts range from $12.00 to $19.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $15.5118 in the next twelve months. This suggests a possible upside of 49.3% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

What is the consensus analysts' recommendation for Allscripts Healthcare Solutions?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. According to Zacks Investment Research, "Allscripts continues to gain from its core software, delivery, support and maintenance units, which projected solid growth in recent times. The company’s growth in revenue cycle services and acquisition of McKesson’s EIS business has lent it a competitive edge. The recently-closed acquisition of HealthGrid is likely to boost its flagship FollowMyHealth patient engagement platform. On the negative side, Allscripts' margins are under pressure due to decline in non-recurring software license revenues in recent times. Year-over-year decline in bookings is a concern. In fact, management expects to see some volatility in bookings in the quarters ahead. The company also witnessed significant contraction in margins lately. The company is exposed to integration risks. Intense competition in the MedTech space adds to woes. Allscripts underperformed the industry in a year's time. " (12/13/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on MDRX shares but lower our 12-month price target to $17 from $18. After the close, August 2, Allscripts reported 2Q18 results. Revenue was below our estimate but in line with FactSet consensus. Adjusted EPS was in line with our estimate. Bookings were disappointing, but the company held its 2018 guidance metrics. Notably, the company appears to be negotiating the sale of its stake in Netsmart, its behavioral IT unit. We had previously estimated that the company’s Netsmart stake was worth about $3 per share before any tax considerations." (8/2/2018)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

Press coverage about MDRX stock has been trending somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of 1.3 on InfoTrie's scale. They also gave media coverage about the software maker a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the stock's share price in the next several days.

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 60)
  • Mr. Richard J. Poulton, Pres (Age 53)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51)

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.07%), Vanguard Group Inc (9.07%), Dimensional Fund Advisors LP (5.76%), Fuller & Thaler Asset Management Inc. (3.83%), Fiduciary Management Inc. WI (3.76%) and Fisher Asset Management LLC (2.85%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Victory Capital Management Inc., Dimensional Fund Advisors LP, Jefferies Group LLC, Community Trust & Investment Co., Candriam Luxembourg S.C.A., Fuller & Thaler Asset Management Inc. and Fort Washington Investment Advisors Inc. OH. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., WINTON GROUP Ltd, Rothschild & Co. Asset Management US Inc., Point72 Asset Management L.P., Vanguard Group Inc, Vanguard Group Inc., Dupont Capital Management Corp and AQR Capital Management LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $10.39.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $1.70 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]

MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  544 (Vote Outperform)
Underperform Votes:  537 (Vote Underperform)
Total Votes:  1,081
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel